Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Chemotherapy
Related studies linked through entity extraction aliases.
XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Randomized Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC).
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
- Status
- RECRUITING
- Phase
- NA
Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE3
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
- Status
- RECRUITING
- Phase
- NA
Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib
- Status
- RECRUITING
- Phase
- PHASE2
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study
- Status
- RECRUITING
- Phase
- PHASE3
Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE1